NCT06915103View on ClinicalTrials.gov

A Case Report of NMDAR Encephalopathy

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

June 20, 2024

Primary Completion Date

July 8, 2024

Study Completion Date

December 19, 2024

Conditions
Anti-NMDA Receptor EncephalitisMature TeratomaParaneoplastic Syndromes
Interventions
DIAGNOSTIC_TEST

Magnetic Resonance Imaging (MRI)

A pelvic MRI with and without contrast was performed for evaluation of the ovary.

PROCEDURE

Salpingo-oophorectomy

Salpingo-oophorectomy procedure was performed on the left ovary.

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06915103 - A Case Report of NMDAR Encephalopathy | Biotech Hunter | Biotech Hunter